Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Danesh

Showing results (141-150 of 309) with videos related to

Pageof 31
Sort By:
Plos Medicine|February 25, 2012
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication biasRobert Clarke, Derrick A Bennett, Sarah Parish, et al.
Heart (British Cardiac Society)|October 6, 2020
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UKSimon Ball, Amitava Banerjee, Colin Berry, et al.
European Journal of Epidemiology|May 2, 2015
The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and designRajiv Chowdhury, Dewan S Alam, Ismail Ibrahim Fakir, et al.
Nature Communications|August 18, 2023
A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiologyParsa Akbari, Dragana Vuckovic, Luca Stefanucci, et al.
Scientific Reports|July 1, 2017
Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood ObesityAudrey E Hendricks, Elena G Bochukova, Gaëlle Marenne, et al.
Nature Genetics|March 4, 2025
The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomesAlex Tokolyi, Elodie Persyn, Artika P Nath, et al.
International Journal of Molecular Epidemiology and Genetics|September 15, 2011
Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery diseaseSally L Ricketts, Katrijn L Rensing, Jeff M Holly, et al.
The Lancet. Public Health|November 1, 2024
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health recordsRobert A Fletcher, Patrick Rockenschaub, Brendon L Neuen, et al.
Journal of the American College of Cardiology|August 9, 2020
Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South AsiansMinxian Wang, Ramesh Menon, Sanghamitra Mishra, et al.
Royal Society Open Science|January 4, 2021
ACE inhibition and cardiometabolic risk factors, lung <i>ACE2</i> and <i>TMPRSS2</i> gene expression, and plasma ACE2 levels: a Mendelian randomization studyDipender Gill, Marios Arvanitis, Paul Carter, et al.
Pageof 31

Showing results (141-150 of 309) with videos related to

Sort By:
Pageof 31
Plos Medicine|February 25, 2012
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication biasRobert Clarke, Derrick A Bennett, Sarah Parish, et al.
Heart (British Cardiac Society)|October 6, 2020
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UKSimon Ball, Amitava Banerjee, Colin Berry, et al.
European Journal of Epidemiology|May 2, 2015
The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and designRajiv Chowdhury, Dewan S Alam, Ismail Ibrahim Fakir, et al.
Nature Communications|August 18, 2023
A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiologyParsa Akbari, Dragana Vuckovic, Luca Stefanucci, et al.
Scientific Reports|July 1, 2017
Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood ObesityAudrey E Hendricks, Elena G Bochukova, Gaëlle Marenne, et al.
Nature Genetics|March 4, 2025
The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomesAlex Tokolyi, Elodie Persyn, Artika P Nath, et al.
International Journal of Molecular Epidemiology and Genetics|September 15, 2011
Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery diseaseSally L Ricketts, Katrijn L Rensing, Jeff M Holly, et al.
The Lancet. Public Health|November 1, 2024
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health recordsRobert A Fletcher, Patrick Rockenschaub, Brendon L Neuen, et al.
Journal of the American College of Cardiology|August 9, 2020
Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South AsiansMinxian Wang, Ramesh Menon, Sanghamitra Mishra, et al.
Royal Society Open Science|January 4, 2021
ACE inhibition and cardiometabolic risk factors, lung <i>ACE2</i> and <i>TMPRSS2</i> gene expression, and plasma ACE2 levels: a Mendelian randomization studyDipender Gill, Marios Arvanitis, Paul Carter, et al.
Pageof 31